Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Total Debt (2016 - 2025)

Mimedx (MDXG) has disclosed Total Debt for 11 consecutive years, with $18.0 million as the latest value for Q4 2025.

  • Quarterly Total Debt fell 4.58% to $18.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.0 million through Dec 2025, down 4.58% year-over-year, with the annual reading at $18.0 million for FY2025, 4.58% down from the prior year.
  • Total Debt hit $18.0 million in Q4 2025 for Mimedx, down from $18.2 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $49.1 million in Q4 2023 to a low of $18.0 million in Q4 2025.
  • Historically, Total Debt has averaged $36.5 million across 5 years, with a median of $48.0 million in 2021.
  • Biggest five-year swings in Total Debt: increased 1.04% in 2023 and later plummeted 61.65% in 2024.
  • Year by year, Total Debt stood at $48.1 million in 2021, then grew by 0.97% to $48.6 million in 2022, then increased by 1.04% to $49.1 million in 2023, then crashed by 61.65% to $18.8 million in 2024, then dropped by 4.58% to $18.0 million in 2025.
  • Business Quant data shows Total Debt for MDXG at $18.0 million in Q4 2025, $18.2 million in Q3 2025, and $18.5 million in Q2 2025.